|
Re: Top-line vs. Full Detailed Clinical Trial Results
|
5
|
Resverlogix Corp.
|
Aug 28, 2018 03:58PM
|
|
Re: Apabetalone......a Calculated Risk
|
5
|
Resverlogix Corp.
|
Apr 09, 2019 08:59AM
|
|
Re: Surprising.....
|
5
|
Resverlogix Corp.
|
Oct 01, 2019 04:07PM
|
|
MD&A and Financials up on SEDAR
|
5
|
Resverlogix Corp.
|
Mar 17, 2018 02:11PM
|
|
Re: Couple interesting tidbits from Financials
|
5
|
Resverlogix Corp.
|
Jul 30, 2019 10:42AM
|
|
Re: So many questions...
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 09:48PM
|
|
Re: Since GAC....
|
5
|
Resverlogix Corp.
|
Feb 28, 2020 04:12PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
5
|
Resverlogix Corp.
|
May 11, 2017 12:32PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 09:35PM
|
|
Re: My guess is a second BTD is coming
|
5
|
Resverlogix Corp.
|
Feb 08, 2020 05:15PM
|
|
Re: If we don`t catch another NR this week ..
|
5
|
Resverlogix Corp.
|
Sep 12, 2016 01:20PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 09:46PM
|
|
Re: 2019 Potential Events
|
5
|
Resverlogix Corp.
|
May 10, 2019 04:43PM
|
|
Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 15, 2016 11:15PM
|
|
Re: Clarification received...
|
5
|
Resverlogix Corp.
|
Jun 09, 2018 03:59PM
|
|
Re: BETonMACE Enrollment
|
5
|
Resverlogix Corp.
|
Aug 18, 2019 01:02PM
|
|
Fierce Biotech BET inhibitor/PD-L1 cancer article
|
5
|
Zenith Epigenetics
|
Sep 15, 2016 10:56AM
|
|
Re: Pondering the biomarkers...
|
5
|
Resverlogix Corp.
|
Nov 22, 2019 01:36PM
|
|
Re: MACE Event rate,....
|
5
|
Resverlogix Corp.
|
Feb 28, 2019 11:32AM
|
|
Re: It will be interesting..
|
5
|
Resverlogix Corp.
|
Nov 25, 2016 10:49AM
|
